VYNE Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q4 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
VYNE Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q4 2024.
- VYNE Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 42.6M shares, a 315% increase year-over-year.
- VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 42.6M shares, a 315% increase from 2023.
- VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 10.3M shares, a 222% increase from 2022.
- VYNE Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.19M shares, a 11.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)